85 related articles for article (PubMed ID: 1568224)
1. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth.
Schirmacher P; Held WA; Yang D; Chisari FV; Rustum Y; Rogler CE
Cancer Res; 1992 May; 52(9):2549-56. PubMed ID: 1568224
[TBL] [Abstract][Full Text] [Related]
2. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
Guo YS; Jin GF; Townsend CM; Zhang T; Sheng HM; Beauchamp RD; Thompson JC
J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
[TBL] [Abstract][Full Text] [Related]
4. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor II induced by hypoxia may contribute to angiogenesis of human hepatocellular carcinoma.
Kim KW; Bae SK; Lee OH; Bae MH; Lee MJ; Park BC
Cancer Res; 1998 Jan; 58(2):348-51. PubMed ID: 9443416
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas.
Casola S; Ungaro P; Pedone PV; Lazzaro D; Fattori E; Ciliberto G; Zarrilli R; Bruni CB; Riccio A
Oncogene; 1995 Aug; 11(4):711-21. PubMed ID: 7651735
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression.
Sargent L; Dragan YP; Babcock K; Wiley J; Klaunig J; Pitot HC
Cancer Res; 1996 Jul; 56(13):2992-7. PubMed ID: 8674053
[TBL] [Abstract][Full Text] [Related]
8. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
9. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers.
Yang D; Alt E; Rogler CE
Cancer Res; 1993 May; 53(9):2020-7. PubMed ID: 8481904
[TBL] [Abstract][Full Text] [Related]
10. The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
Kaplan PJ; Mohan S; Cohen P; Foster BA; Greenberg NM
Cancer Res; 1999 May; 59(9):2203-9. PubMed ID: 10232609
[TBL] [Abstract][Full Text] [Related]
11. Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Nardone G; Romano M; Calabrò A; Pedone PV; de Sio I; Persico M; Budillon G; Bruni CB; Riccio A; Zarrilli R
Hepatology; 1996 Jun; 23(6):1304-12. PubMed ID: 8675143
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor II (IGF-II) mRNA expression during hepatocarcinogenesis in transgenic mice.
Cariani E; Dubois N; Lasserre C; Briand P; Brechot C
J Hepatol; 1991 Sep; 13(2):220-6. PubMed ID: 1720799
[TBL] [Abstract][Full Text] [Related]
13. Expression of insulin-like growth factor II in spontaneously immortalized rat mesothelial and spontaneous mesothelioma cells: a potential autocrine role of insulin-like growth factor II.
Rutten AA; Bermudez E; Stewart W; Everitt JI; Walker CL
Cancer Res; 1995 Aug; 55(16):3634-9. PubMed ID: 7627973
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of insulin-like growth factor-II and its dynamic quantitative analysis at different stages of hepatocellular carcinoma development.
Qiu LW; Yao DF; Zong L; Lu YY; Huang H; Wu W; Wu XH
Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):406-11. PubMed ID: 18693177
[TBL] [Abstract][Full Text] [Related]
15. Role of the insulin-like growth factor system in adrenocortical growth control and carcinogenesis.
Fottner Ch; Hoeflich A; Wolf E; Weber MM
Horm Metab Res; 2004 Jun; 36(6):397-405. PubMed ID: 15241731
[TBL] [Abstract][Full Text] [Related]
16. The role of insulin-like growth factor II in the malignant transformation of rat liver oval cells.
Zhang N; Siegel K; Odenthal M; Becker R; Oesch F; Dienes HP; Schirmacher P; Steinberg P
Hepatology; 1997 Apr; 25(4):900-5. PubMed ID: 9096595
[TBL] [Abstract][Full Text] [Related]
17. Constitutive expression of mature transforming growth factor beta1 in the liver accelerates hepatocarcinogenesis in transgenic mice.
Factor VM; Kao CY; Santoni-Rugiu E; Woitach JT; Jensen MR; Thorgeirsson SS
Cancer Res; 1997 Jun; 57(11):2089-95. PubMed ID: 9187100
[TBL] [Abstract][Full Text] [Related]
18. A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.
Huynh H; Chow PK; Ooi LL; Soo KC
Cell Growth Differ; 2002 Mar; 13(3):115-22. PubMed ID: 11959812
[TBL] [Abstract][Full Text] [Related]
19. An evaluation of the role of insulin-like growth factors (IGF) and of type-I IGF receptor signalling in hepatocarcinogenesis and in the resistance of hepatocarcinoma cells against drug-induced apoptosis.
Alexia C; Fallot G; Lasfer M; Schweizer-Groyer G; Groyer A
Biochem Pharmacol; 2004 Sep; 68(6):1003-15. PubMed ID: 15313394
[TBL] [Abstract][Full Text] [Related]
20. Ontogeny of insulin-like growth factor-I and -II gene expression in ovine fetal heart.
Cheung CY; Johnson DD; Reyes V
J Soc Gynecol Investig; 1996; 3(6):309-15. PubMed ID: 8923414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
